Medicine and Dentistry
Prostate Cancer
100%
Magnetic Resonance Imaging
54%
Malignant Neoplasm
41%
Neoplasm
30%
Adipose Tissue
24%
Cancer
24%
Computer Assisted Tomography
23%
Diseases
23%
Positron Emission Tomography
23%
Sex Difference
21%
Visceral Fat
21%
Metastatic Carcinoma
20%
Biological Marker
18%
Body Mass Index
16%
Multiparametric Magnetic Resonance Imaging
16%
Biopsy Technique
15%
Overall Survival
15%
Polyethylene Terephthalate
15%
Metabolomics
14%
Cancer Cell
14%
Gamma-Aminobutyric Acid
14%
Ganglioglioma
14%
Recurrent Disease
12%
Clear Cell Renal Cell Carcinoma
12%
Transgenic Mouse
12%
Glioblastoma
10%
Cancer Metabolism
10%
Radioactive Tracer
10%
Positron Emission Tomography-Computed Tomography
10%
Glycan
10%
Chemokine Receptor
9%
Oral Cancer
9%
Lipogenesis
9%
Uterine Cancer
9%
Proteomics
9%
Abdominal Aortic Aneurysm
9%
Drive
9%
Prostate Specific Antigen
7%
Risk Stratification
7%
Carcinogenesis
7%
Prostatectomy
7%
Matrix-Assisted Laser Desorption-Ionization
7%
Odds Ratio
7%
In Vitro
7%
Magnetic Resonance Imaging of Prostate
7%
Gamma Chemokine
7%
Metabolite
7%
Localized Disease
7%
Gene Linkage
7%
Tumor Metabolism
6%
Keyphrases
Prostate Cancer
81%
Multiparametric MRI (mpMRI)
46%
Tumor
29%
Sex Differences
27%
Metabolic Pathway
23%
Neuroendocrine Cancer
23%
Prostate
22%
Clinically Significant Prostate Cancer
22%
Visceral Fat
20%
Metabolism
19%
NCCN Guidelines
19%
Computed Tomography
17%
Glycolysis
17%
Positron Emission Tomography
16%
Overall Survival
16%
Body Composition
16%
Magnetic Resonance Imaging
16%
Poor Prognosis
15%
Renal Cell Carcinoma
14%
N-glycan
13%
Cancer Genome Atlas
13%
Obesity
13%
Glioblastoma
11%
Metastasis
11%
In Cancer
11%
Glioma
11%
Neuroendocrine Cells
11%
Positron Emission Tomography-computed Tomography (PET-CT)
11%
Cancer Tissue
11%
Cancer Metabolism
10%
PH-sensitive
10%
Extracellular pH
10%
Sex-specific
10%
Subcutaneous Adipose Tissue
9%
Visceral Adipose Tissue
9%
Recurrent Disease
9%
Bitter Melon Extract
9%
Oral Cancer
9%
Lipogenesis
9%
Theranostic Platform
9%
Spatial Proteomics
9%
Calcium Carbonate Nanoparticles
9%
Cocaine
9%
Acetylcholine Receptor (AChR)
9%
Nicotinic Acetylcholine Receptor (nAChR)
9%
Body Composition Analysis
9%
Neuroendocrine Phenotype
9%
Diffusion Basis Spectrum Imaging
9%
Ruptured Abdominal Aortic Aneurysm (rAAA)
9%
Metastatic Disease
9%